Abstract
Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CAP), are difficult to propagate, and can cause clinically indistinguishable disease patterns. During 2011-2012, we used molecular methods to test adult patients in Germany with confirmed CAP for infection with these 2 pathogens. Overall, 12.3% (96/783) of samples were positive for M. pneumoniae and 3.9% (31/794) were positive for Chlamydia spp.; C. psittaci (2.1%) was detected more frequently than C. pneumoniae (1.4%). M. pneumoniae P1 type 1 predominated, and levels of macrolide resistance were low (3.1%). Quarterly rates of M. pneumoniae-positive samples ranged from 1.5% to 27.3%, showing a strong epidemic peak for these infections, but of Chlamydia spp. detection was consistent throughout the year. M. pneumoniae-positive patients were younger and more frequently female, had fewer co-occurring conditions, and experienced milder disease than did patients who tested negative. Clinicians should be aware of the epidemiology of these pathogens in CAP.
| Original language | English |
|---|---|
| Pages (from-to) | 426-434 |
| Number of pages | 9 |
| Journal | Emerging Infectious Diseases |
| Volume | 21 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Mar 2015 |
Keywords
- TANDEM-REPEAT ANALYSIS
- MICROARRAY-BASED DETECTION
- COMPETENCE NETWORK
- ADULTS
- CHLAMYDOPHILA
- PATHOGENS
- CAPNETZ
- STRAINS
- FRANCE
- EUROPE